Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Amortization - Intangibles: 2017-2025

Historic Amortization - Intangibles for Ptc Therapeutics (PTCT) over the last 8 years, with Sep 2025 value amounting to $7.5 million.

  • Ptc Therapeutics' Amortization - Intangibles rose 148.16% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year decrease of 86.11%. This contributed to the annual value of $60.7 million for FY2024, which is 72.72% down from last year.
  • As of Q3 2025, Ptc Therapeutics' Amortization - Intangibles stood at $7.5 million, which was up 85.52% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Amortization - Intangibles registered a high of $77.2 million during Q4 2023, and its lowest value of $2.9 million during Q2 2024.
  • For the 3-year period, Ptc Therapeutics' Amortization - Intangibles averaged around $27.2 million, with its median value being $7.5 million (2025).
  • In the last 5 years, Ptc Therapeutics' Amortization - Intangibles tumbled by 95.71% in 2024 and then spiked by 148.16% in 2025.
  • Over the past 5 years, Ptc Therapeutics' Amortization - Intangibles (Quarterly) stood at $16.4 million in 2021, then surged by 118.50% to $35.8 million in 2022, then soared by 115.51% to $77.2 million in 2023, then plummeted by 95.71% to $3.3 million in 2024, then spiked by 148.16% to $7.5 million in 2025.
  • Its last three reported values are $7.5 million in Q3 2025, $4.1 million for Q2 2025, and $3.8 million during Q1 2025.